Literature DB >> 26064244

Effect of ginkgolide B on brain metabolism and tissue oxygenation in severe haemorrhagic stroke.

Chun-Ling Chi1, Dong-Fang Shen1, Peng-Jun Wang1, Hu-Lun Li2, Li Zhang1.   

Abstract

Ginkgolide B, a diterpene, is an herbal constituent isolated from the leaves of Ginkgo biloba tree. The present study demonstrates the effect of ginkgolide B in osmotherapy on brain metabolism and tissue oxygenation. Multimodality monitoring including intracranial pressure (ICP), cerebral perfusion pressure (CPP), partial pressure of brain tissue oxygen (PbtO2), lactate/pyruvate ratio (LPR) and microdialysis were employed to study the effect of ginkgolide B osmotherapy. The results demonstrated that administration of 15% solution of ginkgolide B to the comatose patients with raised ICP (> 20 mm Hg) and resistant to standard therapy led to a significant decrease in ICP. The cerebral microdialysis was used to compare mean arterial blood pressure (MAP), ICP, CPP, PbtO2, brain lactate, pyruvate and glucose level after hourly intervals starting 3 h before and up to 4 h after hyperosmolar therapy. There was a decrease in ICP in 45 min from 23 ± 14 mm Hg (P < 0.001) to 18 ± 24 mm Hg and increase in CPP after 1 h of gingkolide B infusion from 74 ± 18 to 85 ± 22 mm Hg (P < 0.002). However there was no significant effect on MAP but PbtO2 was maintained in the range of 22-26. The peak lactate/pyruvate ratio was recorded at the time of initiation of osmotherapy (44 ± 20) with an 18% decrease over 2 h following gingkolide B therapy. Also the brain glucose remained unaffected.

Entities:  

Keywords:  Osmotherapy; infusion; intracranial pressure; microdialysis; perfusion pressure

Year:  2015        PMID: 26064244      PMCID: PMC4443078     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  45 in total

1.  GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data.

Authors:  Sandrine Andrieu; Pierre-Jean Ousset; Nicola Coley; Mehemed Ouzid; Hélène Mathiex-Fortunet; Bruno Vellas
Journal:  Curr Alzheimer Res       Date:  2008-08       Impact factor: 3.498

2.  Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study.

Authors:  Paul Vespa; Marvin Bergsneider; Nayoa Hattori; Hsiao-Ming Wu; Sung-Cheng Huang; Neil A Martin; Thomas C Glenn; David L McArthur; David A Hovda
Journal:  J Cereb Blood Flow Metab       Date:  2005-06       Impact factor: 6.200

3.  Adding insult to injury: the prognostic value of early secondary insults for survival after traumatic brain injury.

Authors:  D F Signorini; P J Andrews; P A Jones; J M Wardlaw; J D Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

4.  Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients.

Authors:  Oliver W Sakowitz; John F Stover; Asita S Sarrafzadeh; Andreas W Unterberg; Karl L Kiening
Journal:  J Trauma       Date:  2007-02

5.  Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide.

Authors:  L J Zhou; X Z Zhu
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

Review 6.  The CNS effects of Ginkgo biloba extracts and ginkgolide B.

Authors:  Karyn M Maclennan; Cynthia L Darlington; Paul F Smith
Journal:  Prog Neurobiol       Date:  2002-06       Impact factor: 11.685

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Ginkgolide B suppresses intercellular adhesion molecule-1 expression via blocking nuclear factor-kappaB activation in human vascular endothelial cells stimulated by oxidized low-density lipoprotein.

Authors:  Rui Li; Beidong Chen; Wei Wu; Li Bao; Jian Li; Ruomei Qi
Journal:  J Pharmacol Sci       Date:  2009-07       Impact factor: 3.337

9.  Blood brain barrier permeability and therapeutic time window of Ginkgolide B in ischemia-reperfusion injury.

Authors:  Weirong Fang; Yan Deng; Yunman Li; Erxin Shang; Fang Fang; Peng Lv; Li Bai; Yan Qi; Fang Yan; Lishun Mao
Journal:  Eur J Pharm Sci       Date:  2009-10-13       Impact factor: 4.384

10.  [Preparation and definition of Ginkgo biloba extract].

Authors:  K Drieu
Journal:  Presse Med       Date:  1986-09-25       Impact factor: 1.228

View more
  4 in total

1.  Ginkgolide B Protects Against Ischemic Stroke via Targeting AMPK/PINK1.

Authors:  Yile Cao; Lei Yang; Hong Cheng
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

2.  Comparing the role of Ginkgolide B and Ginkgolide K on cultured astrocytes exposed to oxygen‑glucose deprivation.

Authors:  Wen-Bo Yu; Liang Cao; Yan-Yin Zhao; Wei Xiao; Bao-Guo Xiao
Journal:  Mol Med Rep       Date:  2018-09-04       Impact factor: 2.952

Review 3.  The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review.

Authors:  Zili Feng; Qian Sun; Wang Chen; Yu Bai; Daihua Hu; Xin Xie
Journal:  Mol Med       Date:  2019-12-21       Impact factor: 6.354

4.  A Single Dose of Ginkgo biloba Extract Induces Gene Expression of Hypothalamic Anorexigenic Effectors in Male Rats.

Authors:  Meira M F Machado; Janilda P Pereira; Bruna K S Hirata; Viviane S Júlio; Renata M Banin; Heider M Andrade; Eliane B Ribeiro; Suzete M Cerutti; Mônica M Telles
Journal:  Brain Sci       Date:  2021-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.